American International Group’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,165
Closed -$420K 2004
2024
Q1
$420K Sell
28,165
-242
-0.9% -$3.99K ﹤0.01% 1748
2023
Q4
$514K Buy
28,407
+209
+0.7% +$3.18K ﹤0.01% 1646
2023
Q3
$489K Buy
28,198
+1,003
+4% +$17.4K ﹤0.01% 1620
2023
Q2
$493K Buy
+27,195
New +$644K ﹤0.01% 1650
2022
Q2
Sell
-11,944
Closed -$84K 3224
2022
Q1
$84K Sell
11,944
-841
-7% -$8.58K ﹤0.01% 2657
2021
Q4
$173K Sell
12,785
-383
-3% -$6.09K ﹤0.01% 2450
2021
Q3
$222K Sell
13,168
-313
-2% -$6.64K ﹤0.01% 2371
2021
Q2
$393 Sell
13,481
-518
-4% -$16.1K ﹤0.01% 2079
2021
Q1
$551 Buy
13,999
+7,943
+131% +$258K ﹤0.01% 1779
2020
Q4
$138 Sell
6,056
-173
-3% -$4.34K ﹤0.01% 2482
2020
Q3
$141K Buy
+6,229
New +$156K ﹤0.01% 2338

Other funds holding PLRX

American International Group's PLRX Position: Q2 2024 in Review

American International Group sold out of Pliant Therapeutics (PLRX) in Q2 2024, closing a stake of 28,165 shares — an estimated $420K sold.

American International Group first reported a position in PLRX in Q3 2020 and held it in 11 quarters. The position peaked at $514K in Q4 2023. 143 funds tracked by Wall St. Rank hold PLRX as of Q2 2024.

  • American International Group reported no remaining Pliant Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 28,165 Pliant Therapeutics shares in Q2 2024, an estimated $420K.
  • American International Group first reported a position in Pliant Therapeutics in Q3 2020 and held it in 11 quarters.
  • American International Group's Pliant Therapeutics position peaked at $514K in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.